Haggarty Paul
Rowett Research Institute, Greenburn Road, Bucksburn, Aberdeen AB21 9SB, UK.
Placenta. 2002 Apr;23 Suppl A:S28-38. doi: 10.1053/plac.2002.0791.
More than 90 per cent of the fat deposition in the fetus occurs in the last 10 weeks of pregnancy during which it increases exponentially to reach a rate of accretion of around 7 g/day close to term. All of the n -3 and n -6 fatty acid structure acquired by the fetus has to cross the placenta and fetal blood is enriched in long chain polyunsaturated fatty acids (LCPUFA) relative to the maternal supply. The placenta may regulate its own fatty acid substrate supply via the action of placental leptin on maternal adipose tissue. Fatty acids cross the microvillous and basal membranes by simple diffusion and via the action of membrane bound and cytosolic fatty acid binding proteins (FABPs). The direction and magnitude of fatty acid flux is mainly dictated by the relative abundance of available binding sites. The fatty acid mix delivered to the fetus is largely determined by the fatty acid composition of the maternal blood although the placenta is able to preferentially transfer the important PUFA to the fetus as a result of selective uptake by the syncytiotrophoblast, intracellular metabolic channelling of individual fatty acids, and selective export to the fetal circulation. Placental FABP polymorphisms may affect these processes. There is little evidence to suggest that placental delivery of fatty acids limits normal fetal growth although the importance of the in utero supply may be to support post-natal development as most of the LCPUFA accumulated by the fetus is stored in the adipose tissue for use in early post-natal life.
胎儿体内超过90%的脂肪沉积发生在孕期的最后10周,在此期间脂肪沉积呈指数级增长,临近足月时达到约7克/天的增长速度。胎儿获取的所有n-3和n-6脂肪酸结构都必须穿过胎盘,相对于母体供应,胎儿血液中富含长链多不饱和脂肪酸(LCPUFA)。胎盘可能通过胎盘瘦素对母体脂肪组织的作用来调节自身的脂肪酸底物供应。脂肪酸通过简单扩散以及膜结合型和胞质型脂肪酸结合蛋白(FABP)的作用穿过微绒毛膜和基底膜。脂肪酸通量的方向和大小主要由可用结合位点的相对丰度决定。输送给胎儿的脂肪酸混合物在很大程度上取决于母体血液的脂肪酸组成,不过由于合体滋养层的选择性摄取、单个脂肪酸的细胞内代谢通道以及向胎儿循环的选择性输出,胎盘能够将重要的多不饱和脂肪酸优先转运给胎儿。胎盘FABP基因多态性可能会影响这些过程。几乎没有证据表明胎盘脂肪酸输送会限制胎儿的正常生长,尽管子宫内供应的重要性可能在于支持产后发育,因为胎儿积累的大部分LCPUFA都储存在脂肪组织中以供出生后早期使用。